상세 컨텐츠

본문 제목

Fill Finish Manufacturing Market - Implications of #COVID19 on Global Industry | Emerging Dynamics

카테고리 없음

by mmvaidya 2020. 6. 22. 19:21

본문

Major Take Away From This Study:

Covid Impact on Fill Finish Manufacturing Market, growth/decline in product type/use cases of Fill Finish Manufacturing Market due to cascaded impact of Covid on Extended Ecosystem.

# How top 50 companies in Fill Finish Manufacturing Market are making rapid shifts in their strategies as we speak here.

# Outside-in view of top 50 companies client and client's clients shifting short-term priorities.

The global fill-finish manufacturing market size is projected to grow from USD 7.5 billion in 2020 to USD 12.1 billion by 2025, at a CAGR of 10.0% during the forecast period. 

The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms. However, the high costs associated with isolators or restricted access barrier systems (RABS) is a factor expected to limit the growth of this market to a certain extent.

Recent developments:

In 2017, Syntegon Technology GmbH (Germany) launched a technologically advanced filling and closing machine, ALF 5000.

# In 2017, IMA S.P.A. (Industria Macchine Automatiche) launched an integrated fill-finish machine, INJECTA.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

The study involved two major activities in estimating the current market size of the fill-finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. 

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments. 

Key Questions Addressed by the Report:

Who are the major market players in the fill-finish manufacturing market?
# What are the regional growth trends and the largest revenue-generating regions in the fill-finish manufacturing market?
# What are the major drivers and challenges in the fill-finish manufacturing market?
# What are the major product segments of the market?
# What are the major end-users for fill-finish manufacturing?

By end user, the contract manufacturing organizations segment is expected to witness the highest growth in the fill-finish manufacturing market during the forecast period.

The contract manufacturing organizations segment is expected to show the highest growth in the forecast period due to increasing outsourcing of fill-finish manufacturing processes from small-sized biopharmaceutical companies and the growing number of new entrants in the biologics manufacturing market.

Major Leaders of the Industry:

The prominent players in the global fill-finish manufacturing market include Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany). 

These players have adopted various growth strategies such as product launches, acquisitions, agreements, partnerships, and expansions to increase their presence in the global fill-finish manufacturing industry.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609

Europe accounted for the largest share of the fill-finish manufacturing market in 2019. 

The large share of Europe in this market is attributed to factors such as growing focus on the development of biosimilar due to the patent expiry of key biologics products. In addition, well-established reimbursement systems for drugs have further enhanced the demand for biologics among patients by making them affordable to consume, and to fulfill this, biopharmaceutical companies have increased their production volumes and expand production capacities.